KRChoksey has come out with its first quarter (April-June’ 21) earnings estimates for the Pharma sector. The brokerage house expects Alembic Pharmaceuticals to report net profit at Rs 215 crore down 28.7% year-on-year (down 14.3% quarter-on-quarter).
Net Sales are expected to decrease by 5.6 percent Y-o-Y (down 1.1 percent Q-o-Q) to Rs 1,266 crore, according to KRChoksey.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 21.4 percent Y-o-Y (down 6.3 percent Q-o-Q) to Rs 320 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More